Rhythm Pharmaceuticals Inc (RYTM.OQ)
RYTM.OQ on NASDAQ Stock Exchange Global Market
22.44USD
12:25pm EDT
22.44USD
12:25pm EDT
Change (% chg)
$0.02 (+0.09%)
$0.02 (+0.09%)
Prev Close
$22.42
$22.42
Open
$22.24
$22.24
Day's High
$22.44
$22.44
Day's Low
$21.93
$21.93
Volume
5,904
5,904
Avg. Vol
39,308
39,308
52-wk High
$33.80
$33.80
52-wk Low
$16.89
$16.89
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 0.00 | -0.410 |
| Sep '17 | 0.00 | -0.445 | |
| Jun '17 | 0.00 | -0.312 | |
| Mar '17 | 0.00 | -0.293 | |
| FY 2016 | Dec '16 | 0.00 | -1.132 |
| Sep '16 | 0.00 | -0.280 | |
| Jun '16 | 0.00 | -0.254 | |
| Mar '16 | 0.00 | -0.241 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Sep-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-19 | 3 | 0.67 | 2.02 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 2 | -0.50 | -0.48 | -0.51 | -- |
| Quarter Ending Sep-18 | 2 | -0.54 | -0.49 | -0.59 | -- |
| Year Ending Dec-18 | 2 | -2.18 | -1.99 | -2.38 | -- |
| Year Ending Dec-19 | 3 | -3.04 | -2.55 | -3.37 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 185.16 | 33.25 | |
| P/E High - Last 5 Yrs. | -- | 283.72 | 45.98 | |
| P/E Low - Last 5 Yrs. | -- | 95.28 | 24.86 | |
| Beta | -- | 0.75 | 0.80 | |
| Price to Sales (TTM) | -- | 137.70 | 7.20 | |
| Price to Book (MRQ) | 4.22 | 19.28 | 5.06 | |
| Price to Tangible Book (MRQ) | 4.25 | 24.18 | 6.69 | |
| Price to Cash Flow (TTM) | -- | 120.88 | 25.20 | |
| % Owned Institutions | 90.16 | 11.42 | 2.26 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.29 | 1.53 | |
| Dividend Yield - 5 Year Avg | -- | 0.20 | 0.76 | |
| Dividend 5 Year Growth Rate | -- | 1.94 | 3.96 | |
| Payout Ratio(TTM) | -- | 9.17 | 20.68 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 81.55 | 8.73 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 97.79 | 11.30 | |
| Sales - 5 Yr. Growth Rate | -- | 33.72 | 8.21 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -14.84 | -66.22 | 22.52 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -28.97 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 47.04 | 10.26 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 45.24 | 10.40 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.64 | 2.53 |
| Current Ratio (MRQ) | 22.42 | 6.01 | 3.61 |
| LT Debt to Equity (MRQ) | 0.00 | 23.49 | 11.52 |
| Total Debt to Equity (MRQ) | 0.00 | 25.92 | 14.21 |
| Interest Coverage (TTM) | -- | -189.88 | 30.35 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 34.63 | 54.09 | |
| Gross Margin - 5 Yr. Avg. | -- | 55.35 | 52.20 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -153.57 | 15.86 | |
| Operating Margin (TTM) | -- | -573.06 | 3.97 | |
| Operating Margin - 5 Yr. Avg. | -- | -165.53 | 11.17 | |
| Pre-Tax Margin (TTM) | -- | -545.71 | 4.62 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -172.26 | 11.49 | |
| Net Profit Margin (TTM) | -- | -534.59 | 1.24 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -172.04 | 7.83 | |
| Effective Tax Rate (TTM) | -- | -0.67 | 31.24 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.14 | 24.26 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 0 | 23,627,894 | 806,826,037 | |
| Net Income/Employee (TTM) | -1,296,500 | 954,925 | 94,789,739 | |
| Receivable Turnover (TTM) | -- | 6.54 | 5.54 | |
| Inventory Turnover (TTM) | -- | 2.39 | 3.44 | |
| Asset Turnover (TTM) | -- | 0.40 | 0.88 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | -0.73 | 10.47 | |
| Return on Assets - 5 Yr. Avg. | -- | 0.66 | 11.49 | |
| Return on Investment (TTM) | -- | -0.71 | 13.13 | |
| Return on Investment - 5 Yr. Avg. | -- | 4.08 | 14.88 | |
| Return on Equity (TTM) | -- | -2.76 | 14.96 | |
| Return on Equity - 5 Yr. Avg. | -- | -0.32 | 16.18 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -150.29 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Rhythm Pharmaceuticals Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 90.16% |
| # of Holders: | 87 |
| Total Shares Held: | 24,598,434 |
| 3 Mo. Net Change: | 28,875 |
| # New Positions: | 3 |
| # Closed Positions: | 0 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 2 |
| # Net Buyers: | 3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.